New Activity
Play Matching Pairs

AE

Nav 1.7

PK/PD

GMT

SCONE model

Ames Test

PO

QD

IL10

MDCK

FDA

CDX/PDX

FTE

FEP

RLM

kinetic solubility

Colo205

IP

WaterMap

DMPK

BID

IC50

ROCK1

LM

Treg

DDI Study

ADME

CYP

HLM

OCI-LY3/OCI-LY10

hERG Test

RRCK

DDR

(nude) BALB c mice

AUC

NSCLC

SW48

SAR

(anrti) PD1 and (anti) PD-L1

TGI model

MET-ID Study

nude mice have a mutation that causes their lack of fur which also makes them have insufficient immune responses - useful to not reject implanted tumors; having both types (nude and not) can serve as comparison/controls

model mammalian cell line (canine)

Drug-Drug Interaction study; studies that are performed to assess the effects/safety of using the potential drug candidate in parallel with other medications

protein; Serine/Threonine kinase; key regulator of actin cytoskeleton and cell polarity

concentration of a compound in solution at the time when an induced precipitate first appears (similar to saturating solution)

Drug Metabolism and Pharmaco-kinetics; safety evaluation of drug candidates: includes categories like bioavailability, half-life, clearance, and metabolic profile; more preclinical

Human Liver Microsome; used in DMPK studies

Ralph Russ Canine Kidney; cell permeability assay

Full Time Equivalent; employee that works at a CRO to do ongoing wet lab work for Schrödinger

once per day, referring to dosing

Interleukin 10; anti-inflammatory cytokine, used as a PD marker

Human Ether-a-go-go Related Gene; toxicity study related to cardiac function

Food and Drug Administration; governing body in US for drug approval

patient derived cell line: colorectal adenocarcinoma

Rat Liver Microsome; used in DMPK studies

Schrödinger software that allows visualization and calculations of the energy of water molecules solvating the binding site of a protein

one ion channel peptide chain being investigated in complex with GMTs

Tumor Growth Inhibition model; T/C: tumor volume in control versus treated mice at a specified time; comparing the rate of growth of treated versus untreated tumors in an animal model

uses bacteria to test whether a given chemical can cause mutations in the DNA of the test organism; more formally, it is a biological assay to assess the mutagenic potential of chemical compounds

Diffuse Large B-Cell Lymphoma cell lines

Area Under the (plasma drug concentration) Curve; reflects the actual body exposure to drug after administration of a dose of the drug; dependent on the rate of elimination of the drug from the body and the dose administered; low AUC = high clearance

software tool used for performing predictive simulations in modeling

Cell-Derived Xenograft/Patient-Derived Xenograft; human tumor samples are cultured as cell lines and implanted into mouse models to test the efficacy of anti-tumor compounds in vivo

Gating Modifier Toxin; venom derived peptides that affect ion channels

in prescriptions, delivered by mouth

Absorption, Distribution, Metabolism, and Excretion; used in PK studies to describe the behavior/activity of a drug in the body

patient derived cell line: colorectal adenocarcinoma

Adverse Event; negative event observed in studies or treatment

Free Energy Perturbation; program used to predict "drugability" characteristics using Schrödinger softwares; compared to actual data in development; physics based method

Intellectual Property; agreements in collaboration deals so that information cannot be stolen

programmed cell death protein; programmed cell death ligand; protein on the surface of cells that has a role in regulating the immune system's response to the cells of the human body by down-regulating the immune system and promoting self-tolerance by suppressing T cell inflammatory activity

Liver Microsome; either human or animal, used as a treatment model

Pharmaco-Kinetic/Pharmaco-Dynamic modeling; pharmacokinetics describes the drug concentration-time courses in body fluids resulting from administration of a certain drug dose; pharmacodynamics is the observed effect resulting from a certain drug concentration; more in humans

Non-Small Cell Lung Cancer; common indication specifically in EGFR/KRAS pathway related studies

DNA Damage Repair

twice per day, referring to dosing

Regulatory T cells; used in studies to measure immune response and disease progression

Structure-Activity Relationship; used to predict biological activity from molecular/chemical structure

cytochromes; class of proteins important for clearance metabolism

Half maximum Inhibitory Condition; according to the FDA, this represents the concentration of a drug that is required for 50% inhibition in vitro

Metabolite Identification study; study to investigate the metabolism of the potential DC and explore why DC is being cleared too slowly/quickly